Please login to the form below

Not currently logged in
Email:
Password:

Dinutuximab beta

This page shows the latest Dinutuximab beta news and features for those working in and with pharma, biotech and healthcare.

EUSA receives European green light for kidney cancer treatment Fotivda

EUSA receives European green light for kidney cancer treatment Fotivda

field.”. The UK-based group has also recently received another EU approval for the rare cancer drug dinutuximab beta as a treatment for high-risk neuroblastoma patients over the age of

Latest news

  • Keytruda and Opdivo backed for new uses in Europe Keytruda and Opdivo backed for new uses in Europe

    Keytruda and Opdivo backed for new uses in Europe. CHMP recommendations also include Trumenba, Dinutuximab beta and Refixia. ... Apeiron Biologics also got the go-ahead for Dinutuximab beta as a treatment for high-risk neuroblastoma, an orphan indication.

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics